Skip to content
Lower risk Drug recall · FDA · Published April 13, 2021

Nomax Dry Eye Test Strips Recall: Subpotent Drug Hazard

Nomax recalls 100 sterile dry eye test strips (50 pouches) due to subpotent drug content. This may not provide proper eye test results. Consumers should contact Nomax for details.

🇺🇸 FDA recall #D-0387-2021DrugNomax ›
Take action

Contact the company

Recalling firmNomax Inc9735 Green Park Industrial Dr · Saint Louis, MO 63123-7241
✎ GovInfoNow plain-language explainer

Nomax is recalling dry eye test strips that may contain less active drug than intended. This could lead to inaccurate eye test results. The recall affects products sold with specific lot and expiration dates. Read more at govinfonow.com/recall/36212-nomax-dry-eye-test-strips-recall-subpotent-drug-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/36212-nomax-dry-eye-test-strips-recall-subpotent-drug-hazard · Updated October 4, 2026 · FDA enforcement record: FDA #D-0387-2021

Cite this page

“Nomax Dry Eye Test Strips Recall: Subpotent Drug Hazard.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36212-nomax-dry-eye-test-strips-recall-subpotent-drug-hazard. Based on FDA recall #D-0387-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0387-2021%22&limit=1).

The FDA announced on April 13, 2021, that Nomax Inc voluntarily recalled Dry Eye Test Fluorescein Sodium Ophthalmic Strips due to subpotent drug risks. The recall affects 78 cartons distributed nationwide.

How to tell if you have it

  • Brand: Nomax
  • Product: Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each)
  • NDC: 51801-008-15
  • Lot: 13336
  • Expiration: EXP 07/23

The hazard

The product is classified as a subpotent drug. The recall was initiated voluntarily by the firm.

Context

GovInfoNow's records show Nomax Inc has two other recalls on record since March 24, 2015. On April 19, 2024, Nomax recalled FUL-GLO Ophthalmic Strips due to impurities risk. Other recent recalls of similar products include Scope Health Optase Dry Eye Drops Recall (April 20, 2026), ImprimisRx Povidone Iodine Ophthalmic Solution Recall (August 24, 2026), and CoValence Laboratories Remedy Gel Hydrocortisone 1% Recall (March 18, 2026).

How to tell if you have this one

Check for the product name 'Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each)'. Look for lot number 13336 and expiration date July 2023.

  • Brand
    Nomax
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number (13336) and expiration date (07/23) on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.5 years after the firm started it.

1. Firm started the recall: Apr 13, 202112. FDA classified it Class III: May 18, 202123. Published in FDA’s Enforcement Report: May 26, 202134. FDA terminated the recall: Sep 28, 2023420212023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0387-2021 (April 13, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0387-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA